Moreover, the higher expression of both IL32 and STK17A gene was found to be associated with worse prognosis of STAD (Kaplan–Meier overall survival analysis, log-rank tests, p = 0.12 and 0.013 for IL32 and STK17A, respectively; Supplementary Fig. 7). This evidence concerns the gene IL32 and gastric adenocarcinoma.